We aimed to characterize the genomic profiles of adenocarcinomas in the gastroesophageal junction in relation to cancers in the esophagus and the stomach. Profiles of gains/losses as well as gene expression profiles were obtained from 27 gastroesophageal adenocarcinomas by means of 32k high-resolution array-based comparative genomic hybridization and 27k oligo gene expression arrays, and putative target genes were validated in an extended series. Adenocarcinomas in the distal esophagus and the gastroesophageal junction showed strong similarities with the most common gains at 20q13, 8q24, 1q21-23, 5p15, 13q34, and 12q13, whereas different profiles with gains at 5p15, 7p22, 2q35, and 13q34 characterized gastric cancers. CDK6 and EGFR were ide...
Oesophageal cancers are prominent worldwide; however, there are few targeted therapies and survival ...
Oesophageal cancers are prominent worldwide; however, there are few targeted therapies and survival ...
Oesophageal cancers are prominent worldwide; however, there are few targeted therapies and survival ...
Survival rates of adenocarcinomas of the gastroesophageal junction (GEJ) are low, because these tumo...
Incidence rates have risen rapidly for esophageal and gastric cardia ade-nocarcinomas. These cancers...
AbstractGene expression levels are regulated at many levels. Integration of genome-wide analyses for...
Gene expression levels are regulated at many levels. Integration of genome-wide analyses for the stu...
Gene expression levels are regulated at many levels. Integration of genome-wide analyses for the stu...
Adenocarcinoma of the gastroesophageal junction is rapidly rising in incidence. It has been proposed...
A more detailed understanding of the somatic genetic events that drive gastrointestinal adenocarcino...
A more detailed understanding of the somatic genetic events that drive gastrointestinal adenocarcino...
A more detailed understanding of the somatic genetic events that drive gastrointestinal adenocarcino...
Simple Summary Cancer of the esophagus is a deadly disease. There are two main subtypes, adenocarcin...
This work was supported by the Intramural Research Program and the following grants from the United ...
PurposeEsophageal, gastroesophageal junction, and gastric adenocarcinoma (herein gastroesophageal ad...
Oesophageal cancers are prominent worldwide; however, there are few targeted therapies and survival ...
Oesophageal cancers are prominent worldwide; however, there are few targeted therapies and survival ...
Oesophageal cancers are prominent worldwide; however, there are few targeted therapies and survival ...
Survival rates of adenocarcinomas of the gastroesophageal junction (GEJ) are low, because these tumo...
Incidence rates have risen rapidly for esophageal and gastric cardia ade-nocarcinomas. These cancers...
AbstractGene expression levels are regulated at many levels. Integration of genome-wide analyses for...
Gene expression levels are regulated at many levels. Integration of genome-wide analyses for the stu...
Gene expression levels are regulated at many levels. Integration of genome-wide analyses for the stu...
Adenocarcinoma of the gastroesophageal junction is rapidly rising in incidence. It has been proposed...
A more detailed understanding of the somatic genetic events that drive gastrointestinal adenocarcino...
A more detailed understanding of the somatic genetic events that drive gastrointestinal adenocarcino...
A more detailed understanding of the somatic genetic events that drive gastrointestinal adenocarcino...
Simple Summary Cancer of the esophagus is a deadly disease. There are two main subtypes, adenocarcin...
This work was supported by the Intramural Research Program and the following grants from the United ...
PurposeEsophageal, gastroesophageal junction, and gastric adenocarcinoma (herein gastroesophageal ad...
Oesophageal cancers are prominent worldwide; however, there are few targeted therapies and survival ...
Oesophageal cancers are prominent worldwide; however, there are few targeted therapies and survival ...
Oesophageal cancers are prominent worldwide; however, there are few targeted therapies and survival ...